Literature DB >> 6386852

Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay.

M A Pfaller, D J Krogstad, G G Granich, P R Murray.   

Abstract

We compared the precision and accuracy of five methods used to measure the concentration of vancomycin in serum: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay (FPIA [TDX; Abbott Laboratories, North Chicago, Ill.]), radioimmunoassay (RIA), and fluorescence immunoassay. Based on an analysis of seven standards and of 106 patient samples, all five methods were accurate, and four (bioassay, high-pressure liquid chromatography, FPIA, and RIA) were also precise. The FPIA was the most precise and the fluorescence immunoassay was the least precise of the methods tested; intrarun coefficients of variation for these two methods were 0.9 to 3.0% versus 8.9 to 14.5%, and interrun coefficients of variation were 2.8 to 8.1% versus 12.2 to 16.2%, respectively. The RIA was inconvenient because it required an extra dilution of the specimen being tested and an additional (64 micrograms/ml) vancomycin standard for specimens with 32 to 64 micrograms of vancomycin per ml. Based on its rapid turnaround time and the stability of its standard curve, we believe that the FPIA is the best method currently available to quantitate vancomycin in the clinical laboratory.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386852      PMCID: PMC271319          DOI: 10.1128/jcm.20.3.311-316.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Sensitive bioassay for vancomycin.

Authors:  C A Walker; B Kopp
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

2.  Use and interpretation of common statistical tests in method-comparison studies.

Authors:  J O Westgard; M R Hunt
Journal:  Clin Chem       Date:  1973-01       Impact factor: 8.327

3.  Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrations.

Authors:  K B Crossley; J C Rotschafer; M M Chern; K E Mead; D E Zaske
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

4.  Diphtheroid prosthetic valve endocarditis. A study of clinical features and infecting organisms.

Authors:  B E Murray; A W Karchmer; R C Moellering
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

Review 5.  Vancomycin revisited.

Authors:  F V Cook; W E Farrar
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

6.  Coryneform bacterial endocarditis: difficulties in diagnosis and treatment, presentation of three cases, and review of literature.

Authors:  R E Van Scoy; S N Cohen; J E Geraci; J A Washington
Journal:  Mayo Clin Proc       Date:  1977-04       Impact factor: 7.616

7.  Artifactual radioassay results due to serum contamination by intravenous radioisotope administration. Falsely low serum vitamin B12 and folic acid results.

Authors:  R Carmel
Journal:  Am J Clin Pathol       Date:  1978-09       Impact factor: 2.493

8.  Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.

Authors:  R C Moellering; D J Krogstad; D J Greenblatt
Journal:  Ann Intern Med       Date:  1981-03       Impact factor: 25.391

9.  Bioassay for determination of vancomycin in the presence of rifampin or aminoglycosides.

Authors:  C N Walker
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

10.  High performance liquid chromatographic assay of vancomycin in serum.

Authors:  J R Uhl; J P Anhalt
Journal:  Ther Drug Monit       Date:  1979       Impact factor: 3.681

View more
  17 in total

1.  Cystatin C and/or creatinine-based estimated glomerular filtration rate for prediction of vancomycin clearance in long-stay critically ill patients with persistent inflammation, immunosuppression and catabolism syndrome (PICS): a population pharmacokinetics analysis.

Authors:  Jingjing Huang; Xiaoli Wang; Chenxia Hao; Wanhua Yang; Weixia Zhang; Jialin Liu; Hongping Qu
Journal:  Intern Emerg Med       Date:  2021-03-16       Impact factor: 3.397

2.  Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers.

Authors:  D P Healy; R E Polk; M L Garson; D T Rock; T J Comstock
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

3.  Vancomycin Serum Concentration Monitoring : The Middle Ground is Best.

Authors:  F Marra; B Cairns; P Jewesson
Journal:  Clin Drug Investig       Date:  1996-08       Impact factor: 2.859

4.  Fluorescence polarization immunoassay for zidovudine.

Authors:  G G Granich; M R Eveland; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

5.  Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusions.

Authors:  D P Healy; J V Sahai; S H Fuller; R E Polk
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

6.  Comparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome".

Authors:  J Sahai; D P Healy; M J Shelton; J S Miller; S J Ruberg; R Polk
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

Review 7.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

8.  Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer.

Authors:  R C Evans; C J Holmes
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

9.  Vancomycin skin tests and prediction of "red man syndrome" in healthy volunteers.

Authors:  R E Polk; D Israel; J Wang; J Venitz; J Miller; J Stotka
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

10.  Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics.

Authors:  Andres F Zuluaga; Maria Agudelo; Carlos A Rodriguez; Omar Vesga
Journal:  BMC Clin Pharmacol       Date:  2009-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.